<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-25271" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Morphine</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Murphy</surname>
            <given-names>Patrick B.</given-names>
          </name>
          <aff>Desert Regional Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bechmann</surname>
            <given-names>Samuel</given-names>
          </name>
          <aff>New Jersey Medical School</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Barrett</surname>
            <given-names>Michael J.</given-names>
          </name>
          <aff>Our Lady's Children's Hospital</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Patrick Murphy declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Samuel Bechmann declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Michael Barrett declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>22</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-25271.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p content-type="pubmed-excerpt">FDA-approved usage of morphine sulfate includes moderate to severe pain that may be acute or chronic. Most commonly used in pain management, morphine provides major relief to patients afflicted with pain. Clinical situations that benefit greatly by medicating with morphine include management of palliative/end-of-life care, active cancer treatment, and vaso-occlusive pain during sickle cell crisis. Morphine also has off-label uses for painful conditions. This activity outlines the indications, mechanism of action, methods of administration, important adverse effects, contraindications, monitoring, and toxicity of morphine, so providers can direct patient therapy to optimal outcomes when pain relief is needed.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Review the mechanism of action of morphine.</p></list-item><list-item><p>Identify the approved and off-label indications for using morphine.</p></list-item><list-item><p>Explain the contraindications and adverse events associated with morphine.</p></list-item><list-item><p>Describe interprofessional team strategies for improving care coordination and communication to properly use morphine to improve patient outcomes in the varied scenarios where it can be effective.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25271&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25271">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-25271.s2" sec-type="Indications">
        <title>Indications</title>
        <p>FDA-approved usage of morphine sulfate includes moderate to severe pain that may be acute or chronic.&#x000a0;Most commonly used in pain management, morphine provides significant relief to patients afflicted with pain.<xref ref-type="bibr" rid="article-25271.r1">[1]</xref>&#x000a0;Clinical situations that benefit significantly&#x000a0;by medicating with morphine include management of palliative/end-of-life care, active cancer treatment, and vaso-occlusive pain during sickle cell crisis. Morphine is widely used off-label for almost any condition that causes pain. In the emergency department, morphine is given for musculoskeletal pain, abdominal pain, chest pain, arthritis, and even headaches when patients fail to respond to first and&#x000a0;second-line&#x000a0;agents.<xref ref-type="bibr" rid="article-25271.r2">[2]</xref>&#x000a0;Morphine is rarely used for procedural sedation. However, for small procedures, physicians will sometimes combine a low dose of morphine with a low dose of benzodiazepine-like lorazepam.</p>
        <p>Patients that are actively having acute coronary syndrome are often&#x000a0;given morphine in the emergency setting before going to the cath lab. Morphine to relieve pain during a myocardial infarction (MI) has been in use since the early 1900s. In 2005, an observational study raised some&#x000a0;concerns,&#x000a0;but there are very&#x000a0;few effective alternatives. Morphine is a potent opioid; it decreases pain, which in turn&#x000a0;leads to a decrease in the activation of the autonomic nervous system. These are desirable effects when a patient is having an MI. Additionally, morphine has hemodynamic side effects that can be beneficial during an MI.<xref ref-type="bibr" rid="article-25271.r3">[3]</xref>&#x000a0;</p>
        <p>Morphine can decrease heart rate, blood pressure, and venous return. Morphine can also stimulate local histamine-mediated processes.<xref ref-type="bibr" rid="article-25271.r4">[4]</xref>&#x000a0;In theory, the combination of these can reduce myocardial oxygen demand.</p>
      </sec>
      <sec id="article-25271.s3" sec-type="Mechanism of Action">
        <title>Mechanism of Action</title>
        <p>Morphine is considered the classic opioid analgesic with which other painkillers are compared. Like other medications in this class, morphine has an affinity for delta, kappa, and mu-opioid receptors.<xref ref-type="bibr" rid="article-25271.r5">[5]</xref>&#x000a0;This drug produces most of its analgesic effects by binding to the mu-opioid receptor within the central nervous system (CNS) and the peripheral nervous system (PNS).<xref ref-type="bibr" rid="article-25271.r6">[6]</xref> The net effect of morphine is the activation of descending inhibitory pathways of the CNS as well as inhibition of the nociceptive afferent neurons of the PNS, which leads to an overall reduction of the nociceptive transmission.</p>
      </sec>
      <sec id="article-25271.s4" sec-type="Administration">
        <title>Administration</title>
        <p>Morphine administration can occur through various vehicles. Its administration is most often via the following routes: orally (PO), intravenously (IV), epidural, and intrathecal. Oral formulations are available in both immediate and extended-release for the treatment of acute and chronic pain. Pain that is more severe and not well controlled may be manageable with single or continuous doses of IV, epidural, and intrathecal formulations.<xref ref-type="bibr" rid="article-25271.r2">[2]</xref> Infusion dosing can vary significantly between patients and largely depends on how naive or tolerant they are to opiates. It is interesting to point out that IV morphine formulation is also commonly given intramuscularly (IM). Morphine is also available as a suppository.<xref ref-type="bibr" rid="article-25271.r7">[7]</xref>&#x000a0;Morphine is widely used&#x000a0;and abused. As a result of this, people have found ways to insufflate (snort) the medication.<xref ref-type="bibr" rid="article-25271.r8">[8]</xref>&#x000a0;Morphine is also available as an oral solution and can be administered sublingually. Sublingual morphine is very&#x000a0;popular in palliative care.</p>
      </sec>
      <sec id="article-25271.s5" sec-type="Adverse Effects">
        <title>Adverse Effects</title>
        <p>Among the more common unwanted effects of morphine use is constipation. This effect occurs via stimulation of mu-opioid receptors on the myenteric plexus, which in turn&#x000a0;inhibits gastric emptying and reduces peristalsis. Other common side effects include central nervous system depression, nausea, vomiting, and urinary retention. Respiratory depression is among the more serious adverse reactions with opiate use that is especially important to monitor in the postoperative patient population.<xref ref-type="bibr" rid="article-25271.r9">[9]</xref>&#x000a0;Other reported side effects include lightheadedness, sedation, and dizziness. Patients often report nausea and vomiting, which&#x000a0;is why in many emergency departments, morphine administration is with an&#x000a0;antiemetic such as ondansetron.<xref ref-type="bibr" rid="article-25271.r10">[10]</xref> Other effects include euphoria, dysphoria, agitation, dry mouth, anorexia, and biliary tract spasm, which is why some physicians will avoid morphine when patients present with right upper quadrant pain and they suspect possible biliary tract pathology. Morphine can also affect the cardiovascular system and reportedly can cause flushing, bradycardia, hypotension, and syncope. It is also important to note that patients can experience pruritis, urticaria, edema, and other skin rashes.</p>
      </sec>
      <sec id="article-25271.s6" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>Morphine is an extremely beneficial medication when used appropriately. However, in certain situations, this medication may be strongly contraindicated. Extreme caution&#x000a0;is necessary with severe respiratory depression and asthma exacerbation cases since morphine can further decrease the respiratory drive. Additionally, morphine should be avoided in cases of previous hypersensitivity reaction and immediately discontinued in the presence of an active reaction.<xref ref-type="bibr" rid="article-25271.r11">[11]</xref>&#x000a0;Caution is also necessary with the concurrent use of monoamine oxidase inhibitors (MAOIs) as these medications have an additive effect with morphine. This combination can then trigger severe hypotension, serotonin syndrome, or increase respiratory depression in patients. GI obstruction is another important contraindication.<xref ref-type="bibr" rid="article-25271.r1">[1]</xref>&#x000a0;It is also considered by many as a contraindication to provide opioids to individuals that have a history of substance misuse, especially if a patient has had a history of abusing opioids. Although this is a very controversial topic,&#x000a0;most clinicians would agree that pain requires management.<xref ref-type="bibr" rid="article-25271.r12">[12]</xref>&#x000a0;However, most will agree and acknowledge that there are alternatives to opioid analgesics.</p>
      </sec>
      <sec id="article-25271.s7" sec-type="Monitoring">
        <title>Monitoring</title>
        <p>The efficacy and therapeutic index of morphine are assessable with a combination of subjective and objective findings. Controlling pain, which is&#x000a0;usually the first symptom&#x000a0;evaluated&#x000a0;in patients,&#x000a0;is the ultimate&#x000a0;goal of morphine use. Other essential parameters requiring monitoring include mental status, blood pressure, respiratory drive, and misuse/overuse.<xref ref-type="bibr" rid="article-25271.r2">[2]</xref> Although it may seem intuitive, it is also important to monitor what other medications a patient is taking. This list includes but is not limited to prescription medications. All patients taking morphine should understand the need to avoid any other substances that could lead to respiratory depression.<xref ref-type="bibr" rid="article-25271.r13">[13]</xref>&#x000a0;These medications include but are not limited to&#x000a0;alcohol, additional opioids, benzodiazepines, and barbiturates. Patients can become apneic at lower doses if combining morphine with any of these substances.</p>
      </sec>
      <sec id="article-25271.s8" sec-type="Toxicity">
        <title>Toxicity</title>
        <p>Morphine can potentially be a lethal medication when not used properly.<xref ref-type="bibr" rid="article-25271.r14">[14]</xref>&#x000a0;It causes a host of symptoms related to depression of the CNS. Severe respiratory depression is the most feared complication of morphine in cases of overdose. Immediate injection of naloxone is required to reverse the effects of morphine.</p>
      </sec>
      <sec id="article-25271.s9" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Ordering and administering morphine requires an interprofessional team of healthcare professionals, including clinicians, mid-level practitioners, nurses, and pharmacists.<xref ref-type="bibr" rid="article-25271.r15">[15]</xref>&#x000a0;However, patients may be transferred throughout the hospital while under the effects of these medications. Morphine use, monitoring, and administration can utilize many resources, including laboratory technologists, pharmacists, and nurses/nursing assistants. Without proper training and careful monitoring, often&#x000a0;starting in the emergency department, patients can develop serious side effects and have adverse reactions to morphine. The clinician is responsible for coordinating the care, which includes&#x000a0;the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Ordering&#x000a0;the drug</p>
          </list-item>
          <list-item>
            <p>Monitoring the patient for signs and symptoms of respiratory depression<xref ref-type="bibr" rid="article-25271.r16">[16]</xref></p>
          </list-item>
          <list-item>
            <p>Administering the drug</p>
          </list-item>
          <list-item>
            <p>Consulting with the pharmacist about the use&#x000a0;of morphine with other medications that can cause respiratory depression.</p>
          </list-item>
          <list-item>
            <p>Consulting&#x000a0;with a&#x000a0;specialist if an overdose or allergic reaction occurs.</p>
          </list-item>
          <list-item>
            <p>Consulting&#x000a0;with the radiology if a patient has received morphine prior to imaging</p>
          </list-item>
          <list-item>
            <p>Consulting&#x000a0;with the cardiologist if using morphine in a STEMI<xref ref-type="bibr" rid="article-25271.r17">[17]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25271.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25271&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25271">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/25271/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=25271">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-25271.s11">
        <title>References</title>
        <ref id="article-25271.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hosseininejad</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Mohammadian Amiri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bozorgi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Montazar</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Firouzian</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Moosazadeh</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Goli Khatir</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Shahbakhti</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Darvishi-Khezri</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Does co-treatment with ultra-low-dose naloxone and morphine provide better analgesia in renal colic patients?</article-title>
            <source>Am J Emerg Med</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>37</volume>
            <issue>6</issue>
            <fpage>1025</fpage>
            <page-range>1025-1032</page-range>
            <pub-id pub-id-type="pmid">30121157</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25271.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barut</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Tun&#x000e7;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>&#x0015e;ahin</surname>
                <given-names>&#x0015e;</given-names>
              </name>
              <name>
                <surname>Ulus</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sazak</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Effects of epidural morphine and levobupivacaine combination before incision and after incision and in the postoperative period on thoracotomy pain and stress response.</article-title>
            <source>Turk J Med Sci</source>
            <year>2018</year>
            <month>Aug</month>
            <day>16</day>
            <volume>48</volume>
            <issue>4</issue>
            <fpage>716</fpage>
            <page-range>716-723</page-range>
            <pub-id pub-id-type="pmid">30119145</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25271.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>El Shora</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>El Beleehy</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Abdelwahab</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Ali</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Omran</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Hassan</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Arafat</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Bilateral Paravertebral Block versus Thoracic Epidural Analgesia for Pain Control Post-Cardiac Surgery: A Randomized Controlled Trial.</article-title>
            <source>Thorac Cardiovasc Surg</source>
            <year>2020</year>
            <month>Aug</month>
            <volume>68</volume>
            <issue>5</issue>
            <fpage>410</fpage>
            <page-range>410-416</page-range>
            <pub-id pub-id-type="pmid">30114712</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25271.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schauer</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Naylor</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Maddry</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Hinojosa-Laborde</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>April</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Trends in Prehospital Analgesia Administration by US Forces From 2007 Through 2016.</article-title>
            <source>Prehosp Emerg Care</source>
            <year>2019</year>
            <season>Mar-Apr</season>
            <volume>23</volume>
            <issue>2</issue>
            <fpage>271</fpage>
            <page-range>271-276</page-range>
            <pub-id pub-id-type="pmid">30118637</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25271.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haghjooy-Javanmard</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ghasemi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Laher</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Zarrin</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Dana</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Vaseghi</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Influence of morphine on TLR4/ NF-kB signaling pathway of MCF-7 cells.</article-title>
            <source>Bratisl Lek Listy</source>
            <year>2018</year>
            <volume>119</volume>
            <issue>4</issue>
            <fpage>229</fpage>
            <page-range>229-233</page-range>
            <pub-id pub-id-type="pmid">30113863</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25271.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leite Junior</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>de Mello Bastos</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Samuels</surname>
                <given-names>RI</given-names>
              </name>
              <name>
                <surname>Carey</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Carrera</surname>
                <given-names>MP</given-names>
              </name>
            </person-group>
            <article-title>Reversal of morphine conditioned behavior by an anti-dopaminergic post-trial drug treatment during re-consolidation.</article-title>
            <source>Behav Brain Res</source>
            <year>2019</year>
            <month>Feb</month>
            <day>01</day>
            <volume>359</volume>
            <fpage>771</fpage>
            <page-range>771-782</page-range>
            <pub-id pub-id-type="pmid">30114434</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25271.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anghelescu</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Morgan</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Frett</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Prajapati</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Gold</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Federico</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Pain Outcomes After Celiac Plexus Block in Children and Young Adults with Cancer.</article-title>
            <source>J Adolesc Young Adult Oncol</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>7</volume>
            <issue>6</issue>
            <fpage>666</fpage>
            <page-range>666-672</page-range>
            <pub-id pub-id-type="pmid">30113244</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25271.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hess</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Lahaye</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Waligora</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Sima</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Jiranek</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Golladay</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>Safety and side-effect profile of intrathecal morphine in a diverse patient population undergoing total knee and hip arthroplasty.</article-title>
            <source>Eur J Orthop Surg Traumatol</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>29</volume>
            <issue>1</issue>
            <fpage>125</fpage>
            <page-range>125-129</page-range>
            <pub-id pub-id-type="pmid">30105593</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25271.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gomtsian</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bannister</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Eyde</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Robles</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dickenson</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Porreca</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Navratilova</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Morphine effects within the rodent anterior cingulate cortex and rostral ventromedial medulla reveal separable modulation of affective and sensory qualities of acute or chronic pain.</article-title>
            <source>Pain</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>159</volume>
            <issue>12</issue>
            <fpage>2512</fpage>
            <page-range>2512-2521</page-range>
            <pub-id pub-id-type="pmid">30086115</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25271.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Han</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Xiong</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Niu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Dang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Du</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Oxycodone versus sufentanil in adult patient-controlled intravenous analgesia after abdominal surgery: A prospective, randomized, double-blinded, multiple-center clinical trial.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>97</volume>
            <issue>31</issue>
            <fpage>e11552</fpage>
            <pub-id pub-id-type="pmid">30075523</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25271.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Custodio</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Botanas</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>de la Pe&#x000f1;a</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Sayson</surname>
                <given-names>LV</given-names>
              </name>
              <name>
                <surname>Abiero</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ryoo</surname>
                <given-names>ZY</given-names>
              </name>
              <name>
                <surname>Cheong</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>HJ</given-names>
              </name>
            </person-group>
            <article-title>The circadian gene, Per2, influences methamphetamine sensitization and reward through the dopaminergic system in the striatum of mice.</article-title>
            <source>Addict Biol</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>24</volume>
            <issue>5</issue>
            <fpage>946</fpage>
            <page-range>946-957</page-range>
            <pub-id pub-id-type="pmid">30091820</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25271.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Davis</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Pasternak</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Behm</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Treating Chronic Pain: An Overview of Clinical Studies Centered on the Buprenorphine Option.</article-title>
            <source>Drugs</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>78</volume>
            <issue>12</issue>
            <fpage>1211</fpage>
            <page-range>1211-1228</page-range>
            <pub-id pub-id-type="pmid">30051169</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25271.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Briggs</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Hafenbreidel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Rumbaugh</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>The role of nonmuscle myosin II in polydrug memories and memory reconsolidation.</article-title>
            <source>Learn Mem</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>25</volume>
            <issue>9</issue>
            <fpage>391</fpage>
            <page-range>391-398</page-range>
            <pub-id pub-id-type="pmid">30115760</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25271.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Zheng</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Zhan</surname>
                <given-names>CG</given-names>
              </name>
            </person-group>
            <article-title>Oligomerization and Catalytic Parameters of Human UDP-Glucuronosyltransferase 1A10: Expression and Characterization of the Recombinant Protein.</article-title>
            <source>Drug Metab Dispos</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>46</volume>
            <issue>10</issue>
            <fpage>1446</fpage>
            <page-range>1446-1452</page-range>
            <pub-id pub-id-type="pmid">30111624</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25271.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gushgari</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Driver</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Steele</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Halden</surname>
                <given-names>RU</given-names>
              </name>
            </person-group>
            <article-title>Tracking narcotics consumption at a Southwestern U.S. university campus by wastewater-based epidemiology.</article-title>
            <source>J Hazard Mater</source>
            <year>2018</year>
            <month>Oct</month>
            <day>05</day>
            <volume>359</volume>
            <fpage>437</fpage>
            <page-range>437-444</page-range>
            <pub-id pub-id-type="pmid">30059885</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25271.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Planelles</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Margarit</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ajo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sastre</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Muriel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Inda</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Esteban</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Peir&#x000f3;</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Health benefits of an adverse events reporting system for chronic pain patients using long-term opioids.</article-title>
            <source>Acta Anaesthesiol Scand</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>63</volume>
            <issue>2</issue>
            <fpage>248</fpage>
            <page-range>248-258</page-range>
            <pub-id pub-id-type="pmid">30109708</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25271.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Manchikanti</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sanapati</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Benyamin</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Atluri</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kaye</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Hirsch</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Reframing the Prevention Strategies of the Opioid Crisis: Focusing on Prescription Opioids, Fentanyl, and Heroin Epidemic.</article-title>
            <source>Pain Physician</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>21</volume>
            <issue>4</issue>
            <fpage>309</fpage>
            <page-range>309-326</page-range>
            <pub-id pub-id-type="pmid">30045589</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
